NSE · AAKAAR · Healthcare
Aakaar Medical Technologies Ltd.
Revenue & net profit by period
Bars = revenue (₹ Cr) · line = net profit (₹ Cr). Straight from disclosed results.
Latest period: revenue ₹68 Cr with net profit ₹7 Cr — a 9.79% net margin, versus 9.77% the period before.
Shareholding
As of 2026-03-31
- Promoter67.05%
- Public21.78%
- DII11.17%
550 shareholders on record
Promoter holding trend
Each disclosed period, oldest to newest
52-week position
Where the current price sits in its yearly band
The band spans 2.15× from low to high.
Risk flags
Derived from disclosed data
No flags raised by the data.
Peer comparison
Trading · ranked #1 of 666 by market cap · medians across 50 industry peers
| Company | Mkt cap | P/E | P/B | ROE | Margin |
|---|---|---|---|---|---|
| Adani Enterprises Limited | ₹3,96,659 Cr | 24.35 | 4.87 | 3.42% | 9.3% |
| Avenue Supermarts Limited | ₹2,52,648 Cr | 383.94 | 10.32 | 12.14% | 4.32% |
| Trent Ltd. | ₹1,59,927 Cr | 92.65 | 22.9 | 24.62% | 8.57% |
| FSN E-Commerce Ventures Ltd. | ₹95,580 Cr | 1236.11 | 66.46 | 13.87% | 1.99% |
| Vishal Mega Mart Limited | ₹50,539 Cr | 56.78 | 6.81 | 11.32% | 6.61% |
| Premier Energies Limited | ₹44,610 Cr | 29.55 | 10.36 | 35.05% | 19.3% |
| Aegis Logistics Limited | ₹43,850 Cr | 106.87 | 7.24 | 14.83% | 10.78% |
| Aditya Infotech Limited | ₹38,417 Cr | 226.85 | 20.46 | 19.61% | 8.72% |
| Redington Limited | ₹24,309 Cr | 15.27 | 2.39 | 14.67% | 1.25% |
| Honasa Consumer Limited | ₹14,510 Cr | 209.37 | 10.28 | 14.16% | 8.36% |
| Aakaar Medical Technologies Ltd.(this company) | — | 14.53 | 1.77 | 12.17% | 0% |
AI analysis
AI-generated · google/gemini-2.5-flashAakaar Medical Technologies Ltd. operates in the Healthcare sector. The company reported a PE ratio of 15.46 and an EPS of 4.68. Its book value stands at 38.49. The return on equity was 12.17% and return on capital employed was 26%. The debt-to-equity ratio is 0.53, with a dividend yield of 0%.
Positives
- +Revenue has consistently grown, increasing from Rs 19.51 Cr in March 2022 to Rs 67.77 Cr in March 2026.
- +Return on capital employed (ROCE) is healthy at 26%.
- +Promoter holding is substantial at 67.05% as of March 31, 2026, indicating strong owner commitment.
- +The debt-to-equity ratio is 0.53, which suggests a manageable level of debt.
Negatives
- −The company's profit margin is 0%, indicating no reported profit relative to revenue.
- −EPS decreased to 4.99 in March 2026 from a high of 6.12 in March 2025.
- −No dividend yield has been reported (0%).
- −Shareholding data shows a significant increase in DII holding from 0% in September 2025 to 11.17% in March 2026, alongside a decrease in public holding.
Financial Performance
Revenue has shown consistent growth, increasing from Rs 19.51 Cr in March 2022 to Rs 67.77 Cr in March 2026. Net profit also rose over this period, from Rs 1.62 Cr in March 2022 to Rs 6.64 Cr in March 2026. The EPS increased from 1.78 in March 2022 to 4.99 in March 2026, though it recorded a high of 6.12 in March 2025.
Profitability & Returns
Aakaar Medical Technologies Ltd. has a ROCE of 26% and an ROE of 12.17%. The company's profit margin is 0%. EPS has fluctuated, reaching a high of 6.12 in March 2025 before declining to 4.99 in March 2026.
Balance Sheet
The company has a debt-to-equity ratio of 0.53, indicating a moderate level of debt relative to its equity. The book value per share is 38.49.
Ownership & Pledges
As of March 31, 2026, promoters held 67.05% of the shares. Public shareholding was 21.78%, while DIIs held 11.17%. Over the period from February 2025 to March 2026, promoter holding remained stable around 67.05%. There are no reported promoter pledges.
Data as of — price: 2026-07-30 · financials: Mar 26 · shareholding: Mar 26. Figures are restated only when the company files again, so a period shown here is the most recent one on record — not necessarily the current quarter.
How this is produced: every figure above is computed from exchange filings and financial data mirrored by IPO Plus — no figure is generated or estimated. This is a factual summary for information and education only. It is not investment advice, not a recommendation to buy, sell or hold any security, and contains no price targets. Verify against the company's filings and the exchanges before any decision.
Back to Aakaar Medical Technologies Ltd.share price & fundamentals